356 related articles for article (PubMed ID: 22191525)
1. Macrolide antibiotics in the ribosome exit tunnel: species-specific binding and action.
Kannan K; Mankin AS
Ann N Y Acad Sci; 2011 Dec; 1241():33-47. PubMed ID: 22191525
[TBL] [Abstract][Full Text] [Related]
2. Interplay between the ribosomal tunnel, nascent chain, and macrolides influences drug inhibition.
Starosta AL; Karpenko VV; Shishkina AV; Mikolajka A; Sumbatyan NV; Schluenzen F; Korshunova GA; Bogdanov AA; Wilson DN
Chem Biol; 2010 May; 17(5):504-14. PubMed ID: 20534348
[TBL] [Abstract][Full Text] [Related]
3. The structure of ribosome-lankacidin complex reveals ribosomal sites for synergistic antibiotics.
Auerbach T; Mermershtain I; Davidovich C; Bashan A; Belousoff M; Wekselman I; Zimmerman E; Xiong L; Klepacki D; Arakawa K; Kinashi H; Mankin AS; Yonath A
Proc Natl Acad Sci U S A; 2010 Feb; 107(5):1983-8. PubMed ID: 20080686
[TBL] [Abstract][Full Text] [Related]
4. Species-specific antibiotic-ribosome interactions: implications for drug development.
Wilson DN; Harms JM; Nierhaus KH; Schlünzen F; Fucini P
Biol Chem; 2005 Dec; 386(12):1239-52. PubMed ID: 16336118
[TBL] [Abstract][Full Text] [Related]
5. Macrolide antibiotic interaction and resistance on the bacterial ribosome.
Poehlsgaard J; Douthwaite S
Curr Opin Investig Drugs; 2003 Feb; 4(2):140-8. PubMed ID: 12669373
[TBL] [Abstract][Full Text] [Related]
6. On the specificity of antibiotics targeting the large ribosomal subunit.
Wilson DN
Ann N Y Acad Sci; 2011 Dec; 1241():1-16. PubMed ID: 22191523
[TBL] [Abstract][Full Text] [Related]
7. Molecular insights into 14-membered macrolides using the MM-PBSA method.
Yam WK; Wahab HA
J Chem Inf Model; 2009 Jun; 49(6):1558-67. PubMed ID: 19469526
[TBL] [Abstract][Full Text] [Related]
8. Macrolide antibiotics: binding site, mechanism of action, resistance.
Gaynor M; Mankin AS
Curr Top Med Chem; 2003; 3(9):949-61. PubMed ID: 12678831
[TBL] [Abstract][Full Text] [Related]
9. The structural basis of macrolide-ribosome binding assessed using mutagenesis of 23S rRNA positions 2058 and 2059.
Pfister P; Jenni S; Poehlsgaard J; Thomas A; Douthwaite S; Ban N; Böttger EC
J Mol Biol; 2004 Oct; 342(5):1569-81. PubMed ID: 15364582
[TBL] [Abstract][Full Text] [Related]
10. Binding and action of CEM-101, a new fluoroketolide antibiotic that inhibits protein synthesis.
Llano-Sotelo B; Dunkle J; Klepacki D; Zhang W; Fernandes P; Cate JH; Mankin AS
Antimicrob Agents Chemother; 2010 Dec; 54(12):4961-70. PubMed ID: 20855725
[TBL] [Abstract][Full Text] [Related]
11. Binding site of macrolide antibiotics on the ribosome: new resistance mutation identifies a specific interaction of ketolides with rRNA.
Garza-Ramos G; Xiong L; Zhong P; Mankin A
J Bacteriol; 2001 Dec; 183(23):6898-907. PubMed ID: 11698379
[TBL] [Abstract][Full Text] [Related]
12. Context-specific action of macrolide antibiotics on the eukaryotic ribosome.
Svetlov MS; Koller TO; Meydan S; Shankar V; Klepacki D; Polacek N; Guydosh NR; Vázquez-Laslop N; Wilson DN; Mankin AS
Nat Commun; 2021 May; 12(1):2803. PubMed ID: 33990576
[TBL] [Abstract][Full Text] [Related]
13. Macrolide myths.
Mankin AS
Curr Opin Microbiol; 2008 Oct; 11(5):414-21. PubMed ID: 18804176
[TBL] [Abstract][Full Text] [Related]
14. Selective protein synthesis by ribosomes with a drug-obstructed exit tunnel.
Kannan K; Vázquez-Laslop N; Mankin AS
Cell; 2012 Oct; 151(3):508-20. PubMed ID: 23101624
[TBL] [Abstract][Full Text] [Related]
15. The bacterial ribosome as a target for antibiotics.
Poehlsgaard J; Douthwaite S
Nat Rev Microbiol; 2005 Nov; 3(11):870-81. PubMed ID: 16261170
[TBL] [Abstract][Full Text] [Related]
16. Time-resolved binding of azithromycin to Escherichia coli ribosomes.
Petropoulos AD; Kouvela EC; Starosta AL; Wilson DN; Dinos GP; Kalpaxis DL
J Mol Biol; 2009 Jan; 385(4):1179-92. PubMed ID: 19071138
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of drug-ribosome interactions defines the cidality of macrolide antibiotics.
Svetlov MS; Vázquez-Laslop N; Mankin AS
Proc Natl Acad Sci U S A; 2017 Dec; 114(52):13673-13678. PubMed ID: 29229833
[TBL] [Abstract][Full Text] [Related]
18. On the mechanism of action of 9-O-arylalkyloxime derivatives of 6-O-mycaminosyltylonolide, a new class of 16-membered macrolide antibiotics.
Karahalios P; Kalpaxis DL; Fu H; Katz L; Wilson DN; Dinos GP
Mol Pharmacol; 2006 Oct; 70(4):1271-80. PubMed ID: 16873579
[TBL] [Abstract][Full Text] [Related]
19. Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria.
Schlünzen F; Zarivach R; Harms J; Bashan A; Tocilj A; Albrecht R; Yonath A; Franceschi F
Nature; 2001 Oct; 413(6858):814-21. PubMed ID: 11677599
[TBL] [Abstract][Full Text] [Related]
20. Binding site of the bridged macrolides in the Escherichia coli ribosome.
Xiong L; Korkhin Y; Mankin AS
Antimicrob Agents Chemother; 2005 Jan; 49(1):281-8. PubMed ID: 15616307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
